Navigation Links
New national clinical trials network for neurological disorders to foster cutting-edge treatments
Date:9/12/2012

DALLAS Sept. 13, 2012 UT Southwestern Medical Center's expertise in neurology has earned it a place in an innovative national clinical trials network that will make it easier to test promising treatments for patients with brain, muscle and nerve disorders.

UT Southwestern, one of 25 sites selected for the National Institute of Neurological Disorders and Stroke's (NINDS) new Network for Excellence in Neuroscience Clinical Trials, is the only participating medical center in Texas and its bordering states.

The network, known as NeuroNEXT, represents a unique model of clinical trials for brain diseases. By creating a shared infrastructure and institutional review board, institute officials said they expect to minimize the time and expense of studies while making new treatments available to patients more quickly.

"We want to bring the fruits of discovery in the laboratory as quickly as we can to the patients who need them," said Dr. Mark Goldberg, chairman of neurology and neurotherapeutics at UT Southwestern and a co-principal investigator for the project. "It is more efficient to have a well-organized team in place, allowing us to test one therapy after the next."

UT Southwestern is expected to receive $1.4 million in NINDS support over the next seven years for its role in the network.

Dr. Petra Kaufmann, the NINDS' associate director for clinical research, said UT Southwestern was an excellent candidate for NeuroNEXT because of the medical center's breadth of multidisciplinary expertise across the subspecialties of neurology, neurological surgery and neuroradiology for pediatrics and adults. She also cited the medical center's clinical research experience and access to a large patient population.

"An important piece was the strength in the coordination and collaboration of the investigators," Dr. Kaufmann said. "UT Southwestern also is built on solid basic science enterprise and has translational research capacity. This really was a very good fit."

NeuroNEXT's first clinical trial is designed to identify biomarkers for spinal muscular atrophy (SMA), a motor-neuron disease that causes progressive weakness and respiratory disease. It is the most common genetic cause of death in infants, and those with the most aggressive form of the disease often die before they are 2 years old. There currently is no effective treatment or cure.

UT Southwestern's participation in the trial includes Dr. Susan Iannaccone, a NeuroNEXT co-principal investigator who treats one of the nation's largest populations of spinal muscular atrophy patients. In 2000, she set up one of the disease's first national clinical trial groups, which was expanded from five sites to 15 through two rounds of funding from the National Institutes of Health.

Although successful, that earlier network required expensive and time-consuming planning and execution, said Dr. Iannaccone, professor of pediatrics and of neurology and neurotherapeutics at UT Southwestern. Centralizing those efforts through NeuroNEXT, she said, will allow investigators to focus on research and treatment.

"This means the future is brighter for our patients," said Dr. Iannaccone, who also is director of pediatric neurology at Children's Medical Center. "The faster you can test drugs, the faster you can find out if they work."


'/>"/>
Contact: Jeff Carlton
jeffrey.carlton@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Hospital for Special Surgery investigators receive National Football League grant for PRP research
2. Lights off? International experts call attention to dangers of exposure to light at night
3. Curbing Suicide Now a National Priority, U.S. Says
4. National deficit outlook unchanged under Obama: UMD policy analysis
5. National survey of economists uncovers vast gender gap in policy views
6. Queens University Belfast wins national environment award
7. Canada needs national approach to protect against drug shortages
8. ACP physician wins national award for internal medicine education
9. Researchers awarded National Cancer Institute grants aimed at answering provocative questions
10. International academic publishers join Committee on Publication Ethics
11. National Hartford Centers of Gerontological Nursing Excellence awards new fellows, scholars
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New national clinical trials network for neurological disorders to foster cutting-edge treatments
(Date:10/13/2017)... ... 13, 2017 , ... The International Association of Eating Disorders ... for the field of eating disorders, announces the opening of early registration for ... Florida at the Omni Resort at ChampionsGate. , The annual iaedp™ ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
Breaking Medicine Technology: